photo of Dr Declan Turner

Dr Declan Turner

Dr Declan Turner

Details

Role Postdoctoral Researcher
Research area Stem Cell Medicine
Dr Declan Turner is a postdoctoral researcher in the Lung Disease group lead by Dr Rhiannon Werder at the Murdoch Children’s Research Institute. His research uses induced pluripotent stem cell-derived lung models to study respiratory viral infections, namely human rhinovirus and respiratory syncytial virus.

Declan completed a Bachelor of Science from Monash University in 2016, majoring in microbiology and immunology. He went on to complete an honours project at the Monash Biomedicine Discovery Institute in 2018 under the supervision of Dr Rommel Mathias investigating replication mechanisms of human cytomegalovirus (HCMV), an important pathogen of the immunocompromised. In 2019, he was awarded an Australian Government RTP scholarship to continue his research on HCMV where he specifically focussed on the molecular mechanisms driving virion assembly, envelopment and egress using classical virology and systems biology approaches. In 2022, he was awarded the CSL Prize for this work which recognises the top PhD thesis in the Monash Microbiology Department.
Dr Declan Turner is a postdoctoral researcher in the Lung Disease group lead by Dr Rhiannon Werder at the Murdoch Children’s Research Institute. His research uses induced pluripotent stem cell-derived lung models to study respiratory viral...
Dr Declan Turner is a postdoctoral researcher in the Lung Disease group lead by Dr Rhiannon Werder at the Murdoch Children’s Research Institute. His research uses induced pluripotent stem cell-derived lung models to study respiratory viral infections, namely human rhinovirus and respiratory syncytial virus.

Declan completed a Bachelor of Science from Monash University in 2016, majoring in microbiology and immunology. He went on to complete an honours project at the Monash Biomedicine Discovery Institute in 2018 under the supervision of Dr Rommel Mathias investigating replication mechanisms of human cytomegalovirus (HCMV), an important pathogen of the immunocompromised. In 2019, he was awarded an Australian Government RTP scholarship to continue his research on HCMV where he specifically focussed on the molecular mechanisms driving virion assembly, envelopment and egress using classical virology and systems biology approaches. In 2022, he was awarded the CSL Prize for this work which recognises the top PhD thesis in the Monash Microbiology Department.

Top Publications

  • Turner, DL, Amoozadeh, S, Baric, H, Stanley, E, Werder, RB. Building a human lung from pluripotent stem cells to model respiratory viral infections.. Respir Res 25(1) : 277 2024
    view publication
  • Turner, DL, Fritzlar, S, Sadeghipour, S, Barugahare, AA, Russ, BE, Turner, SJ, Mathias, RA. UL49 is an essential subunit of the viral pre-initiation complex that regulates human cytomegalovirus gene transcription.. iScience 25(10) : 105168 2022
    view publication
  • Turner, DL, Templin, RM, Barugahare, AA, Russ, BE, Turner, SJ, Ramm, G, Mathias, RA. UL34 Deletion Restricts Human Cytomegalovirus Capsid Formation and Maturation.. Int J Mol Sci 23(10) : 2022
    view publication
  • Turner, DL, Mathias, RA. The human cytomegalovirus decathlon: Ten critical replication events provide opportunities for restriction.. Front Cell Dev Biol 10: 1053139 2022
    view publication
  • Turner, DL, Korneev, DV, Purdy, JG, de Marco, A, Mathias, RA. The host exosome pathway underpins biogenesis of the human cytomegalovirus virion.. Elife 9: 2020
    view publication

Career information